Navigation Links
New Cancer Treatment Device Goes Into Service Today
Date:7/25/2011

,000 people in the UK diagnosed with cancer each year[2]. Of these 50,000 people are estimated to develop either primary or secondary brain tumours[3], where traditional treatment is difficult to provide. Malignant primary brain tumours take more years off the average person's life than any other cancer and are the most significant cause of cancer death amongst men under 45 years and women under 35[1].

Ms Tina Karabatsou, Consultant Neurosurgeon at the Salford Royal NHS Foundation Trust, says: "One of the fantastic advantages of the new Novalis Tx treatment is we will be able to treat brain conditions we were previously unable to treat; such as tumours really deep in the brain where open surgery is too dangerous. Equally important is the non-invasive nature of treatment, which means treatment sessions can be performed as an outpatient day-case and with significantly less side effects."

The launch of the high-quality treatment coincides with new guidelines released by the NHS National Cancer Action Team which state that radiosurgery should be made available to all suitable cancer patients in England. By the end of 2011 three sites will be treating with the Novalis Tx developed by Varian Medical Systems and Brainlab in England and Scotland, improving access to advanced cancer care to patients across the UK.

Helen Bulbeck, Director of patient charity Brainstrust, comments: "The launch of the Novalis Tx system is a huge stride towards modernising cancer care in the UK to levels seen in Europe and the US. This is a great achievement for brain tumour treatment and one that we hope to see the NHS continue to build on in the years to come."

Further information:

About Brainlab

Brainlab develops, manufactures and markets software-driven medical technology that supports targeted, less-invasive treatment. Core products are image-guided systems and software that provide real-t
'/>"/>

SOURCE Brainlab
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
4. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
5. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
6. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
7. Novel Technology Breaks Through Cancer Pain
8. CEL-SCI Secures Manufacturing Facility for Multikine Cancer Drug
9. Furamidine Found to Inhibit a Key Enzyme Involved in Cancer Cell DNA Repair Mechanisms
10. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
11. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... BASKING RIDGE, N.J. , Oct. 22, 2014 ... (RMANJ), a world-renowned leader in the field ... more rapid approach to embryonic screening. The research ... American Society for Reproductive Medicine (ASRM) meeting in ... chromosome screening (CCS) and single gene defect (SGD) ...
(Date:10/22/2014)... AVACEN Medical announced today that its AVACEN ... clearance by the U.S. Food and Drug Administration. This ... the Internet for: the temporary relief of joint ... and sprains . Logo - http://photos.prnewswire.com/prnh/20141021/153513 ... is a sophisticated medical device incorporating over 3,000 firmware ...
(Date:10/22/2014)... 22, 2014  With a vision to ensure ... a Global Pharmaceutical and Biotech manufacturer selects and ... turnkey solution to protect their animal health brand.  ... Photo - http://photos.prnewswire.com/prnh/20141021/153439 ... and aggregated by the Xyntek and Antares solution ...
Breaking Medicine Technology:New IVF Research Highlights Improved Genetic Screening Approach To Help Parents Have Healthier Babies 2New IVF Research Highlights Improved Genetic Screening Approach To Help Parents Have Healthier Babies 3AVACEN Medical Announces FDA Clearance of First Medical Device with Internal Game Mode 2Xyntek and Antares Serialization Solution Protects Pets Too! 2
... MIAMI, Jan. 23, 2012  (OTC: IFIX) Internal Fixation Systems ... the FDA to market subtalar implants. These implants are ... to treat both trauma conditions and arthritis.  IFS CEO, ... to continue to fill out our portfolio, and gives ...
... 23, 2012  Virtify, Inc., will host an online roundtable ... open discussion by senior executives from four multinational pharmaceutical ... taking to comply with the July 2, 2012 EVMPD ... (Logo: http://photos.prnewswire.com/prnh/20110131/NE38689LOGO ) Roundtable ...
Cached Medicine Technology:Internal Fixation Systems Announces 510(k) Approval Granted by FDA for Subtalar Implants 2Roundtable of Industry Experts to Discuss Impact, Implications of EVMPD Mandate 2
(Date:10/25/2014)... Mesothelioma researchers are reporting extended survival ... (Alimta), after his combination drug therapy became too toxic. ... just posted on the Surviving Mesothelioma website. , ... in Japan suggests that “maintenance therapy” with pemetrexed may ... cannot tolerate higher doses of cisplatin. , “Although ...
(Date:10/25/2014)... FRIDAY, Oct. 24, 2014 (HealthDay News) -- Not getting ... of ulcerative colitis, a new study suggests. Those ... to eight hours per night may be more prone ... the intestines, researchers report. The study authors concluded that ... be considered among patients with inflammatory bowel diseases. ...
(Date:10/25/2014)... Dotinga HealthDay Reporter FRIDAY, ... are developed that spot increased risks for certain cancers, one ... getting screened. But a new study suggests that, at ... who found out their genes doubled their risk of colon ... to get screened. "It didn,t make any difference, not ...
(Date:10/22/2014)... On October 22, CBS will air an episode ... fictional and real. The Charles E Holman Morgellons ... advocacy and philanthropy in the battle against Morgellons Disease, ... impart truth and clarity about this misunderstood and routinely ... about Morgellons Disease (MD) and most people ...
(Date:10/22/2014)... Norton HealthDay Reporter , TUESDAY, ... the three Ebola cases in Dallas. But, mental health specialists ... Americans. President Barack Obama on Friday appointed an Ebola ... has infected two Dallas nurses who cared for a Liberian ... Presbyterian Hospital. But the U.S. cases are miniscule in ...
Breaking Medicine News(10 mins):Health News:New Report Illustrates Extended Mesothelioma Survival with “Maintenance Therapy”, According to Surviving Mesothelioma 2Health News:Sleep Duration Linked to Ulcerative Colitis Risk in Study 2Health News:Knowing Genetic Risk for Cancer May Not Change Behavior 2Health News:CBS’ Criminal Minds takes aim at skin disease with Morgellons in the Mix 2Health News:CBS’ Criminal Minds takes aim at skin disease with Morgellons in the Mix 3Health News:Ebola Anxiety: A Bigger Threat Now Than the Virus Itself 2Health News:Ebola Anxiety: A Bigger Threat Now Than the Virus Itself 3
... , WELLESLEY HILLS, Mass., Sept. 1 Joseph ... Gastrointestinal Early Development Candidate Program will be part of the ... auction. , , The P2Y2, an ... agonist for treatment of constipation. , , ...
... , WASHINGTON, Sept. 1 , , WHAT: Chronic viral hepatitis ... cirrhosis that costs the nation,s health system hundreds of, ... attention. As many as 2 million people in the United States are, ... chronically infected with hepatitis C. However, most do ...
... suggests students should be wary when walking around parking ... -- Here,s some disturbing research to kick off the ... every six drivers near schools is distracted. , A ... phones, grooming, drinking, eating, smoking and even reading -- ...
... , , , ... member hospitals and suppliers to enable the healthcare industry to utilize ... Location Number (GLN), in transactions through the GHX exchange, which is ... of the standard. With guidance from members of the GHX industry ...
... NEW YORK, Sept. 1 Green parenting -- more than ... babies with lasting results. Parents today feel overwhelmed by all the choices ... Organic Guide to Baby,s First 24 Months (HarperPaperbacks: September ... why "going green" is universally the best way to protect baby from ...
... a Critical Time , , ATLANTA, Sept. 1 ... historical turning point. The country is now embroiled in ... massive for medical device, diagnostic, biopharmaceutical, healthcare information system, ... and investors. , At this critical junction and in ...
Cached Medicine News:Health News:EPIX Pharmaceuticals, Inc. Announces the P2Y2 Gastrointestinal Early Development Candidate Program Will Be Part of the Intellectual Property Offered For Sale at the September 30, 2009 Auction 2Health News:National Summit on Viral Hepatitis to be Held September 10-11 in Washington, D.C. 2Health News:National Summit on Viral Hepatitis to be Held September 10-11 in Washington, D.C. 3Health News:Drivers Distracted When Near Schools 2Health News:GHX Working with Hospitals and Suppliers to Enable Use of Industry Standard Location and Organization Identifiers in Transactions and Compliance with GLN Sunrise Date 2Health News:GHX Working with Hospitals and Suppliers to Enable Use of Industry Standard Location and Organization Identifiers in Transactions and Compliance with GLN Sunrise Date 3Health News:GHX Working with Hospitals and Suppliers to Enable Use of Industry Standard Location and Organization Identifiers in Transactions and Compliance with GLN Sunrise Date 4Health News:Green Parenting is Best for Baby's Health and Happiness While Much Easier and Affordable Than Many Parents Know 2Health News:Green Parenting is Best for Baby's Health and Happiness While Much Easier and Affordable Than Many Parents Know 3Health News:7th Annual Healthcare M A and Business Development Conference, September 9-10, 2009, Atlanta, GA 2
... patented ratchet design provides fingertip ratchet disengagement ... I Instrument program offers state-of-the-art quality in ... maintaining strength and durability. Low profile cutting ... joint spaces. Series I instruments are available ...
Leg holder for arthroscopy....
Irrigation pump for arthroscopy....
The 300 watt Xenon light source will provide intense illumination necessary for demanding, advanced endoscopic procedures....
Medicine Products: